Mark W. Schwartz is President at Galena Biopharma, Inc. (GALE). They have made 1 open-market trade across 1 company since 2014, most recently 2016-07-01.
CIK 0001422882
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GALE | SELL | 2014-01-30 | 2014-01-31 | $5.57 | $557K | -48.6% | -1.4% | -1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.